News

Such exclusivity extends through 25 July 2015 and is expected to be supplemented by a 30-month stay under the Hatch-Waxman Amendments that would be triggered after patent infringement

Self Regional Healthcare will support the Clemson University Center for Human Genetics with a gift of $5.6m over three years. The gift consists of an initial contribution of

This financing will fuel further international expansion, new product development and launches. It will continue to support GC Aesthetics’ vision to become the world’s leading independent medical aesthetics

Treatment will be carried out in CF patients aged six and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

The MHRA has agreed to act as the Reference Member State for this Decentralised Procedure, which will include the UK, Denmark and Sweden. Elvanse is the first long-acting

The CHMP’s recommendation is now referred to the European Commission (EC) and if approved, the company will receive marketing authorization for Vimizim in all EU Member States. The

CVac is a personalized immunocellular therapeutic product and is currently under investigation for the treatment of epithelial ovarian cancer. The drug is intended to stimulate the immune system

The main aim of the deal is to increase the volume of clinical trials carried out in Germany, improve access to commercial clinical research for patients, accelerate the

Preeclampsia is one of the most common medical complications of pregnancy, and if left untreated it can progress to eclampsia, the life-threatening occurrence of seizures during pregnancy. It